139 related articles for article (PubMed ID: 12017810)
1. From policy to action: access to essential drugs for the treatment of hypertension in the Small Island States (SIS) of the South Pacific.
Bailey MC; Azam AA; Galea G; Rotem A
Pac Health Dialog; 2001 Mar; 8(1):103-9. PubMed ID: 12017810
[TBL] [Abstract][Full Text] [Related]
2. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
[TBL] [Abstract][Full Text] [Related]
3. Interview: Mr. Faysal Abdel-Gadir, UNFPA Country Director for Fiji, Kiribati, Nauru, Solomon Islands, Tonga, Trust Territory of the Pacific Islands, Tuvalu and Vanuatu, Papua New Guinea, Samoa, Cook Islands, Niue, Tokelau, Palau, Marshall Islands and Federated States of Micronesia.
Asia Pac POPIN Bull; 1992 Jun; 4(2):8-12. PubMed ID: 12317837
[TBL] [Abstract][Full Text] [Related]
4. Access to Antihypertensive Drugs in China.
Bai G; Bennet C; Wang J; Anderson GF
Circulation; 2018 Oct; 138(17):1777-1779. PubMed ID: 30354658
[No Abstract] [Full Text] [Related]
5. Access to essential drugs in Guyana: a public health challenge.
Seoane-Vazquez E; Rodriguez-Monguio R
Int J Health Plann Manage; 2010; 25(1):2-16. PubMed ID: 18536003
[TBL] [Abstract][Full Text] [Related]
6. [Access for all to quality drugs].
Videau JY
Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
[TBL] [Abstract][Full Text] [Related]
7. Access to essential drugs, human rights and global justice.
Shalev C
Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
[No Abstract] [Full Text] [Related]
8. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
9. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension.
Xu KT; Moloney M; Phillips S
Am J Manag Care; 2003 Aug; 9(8):529-36. PubMed ID: 12921230
[TBL] [Abstract][Full Text] [Related]
10. Interview: Mr. Stephen Chee, team leader, UNFPA country support team (CST) for the South Pacific.
Asia Pac POPIN Bull; 1993 Sep; 5(3):13-5. PubMed ID: 12319033
[TBL] [Abstract][Full Text] [Related]
11. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs.
Chaudhury RR; Parameswar R; Gupta U; Sharma S; Tekur U; Bapna JS
Health Policy Plan; 2005 Mar; 20(2):124-36. PubMed ID: 15746221
[TBL] [Abstract][Full Text] [Related]
12. The morally uncomfortable global drug gap.
Cohen-Kohler JC
Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
[TBL] [Abstract][Full Text] [Related]
13. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
14. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
15. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off?
Carasso BS; Lagarde M; Tesfaye A; Palmer N
Trop Med Int Health; 2009 Nov; 14(11):1394-400. PubMed ID: 19754520
[TBL] [Abstract][Full Text] [Related]
16. Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries.
Ait-Khaled N; Enarson DA; Bissell K; Billo NE
Allergy; 2007 Mar; 62(3):230-6. PubMed ID: 17298339
[TBL] [Abstract][Full Text] [Related]
17. Access to medicines and global health: will Canada lead or flounder?
Orbinski J
CMAJ; 2004 Jan; 170(2):224-6. PubMed ID: 14734437
[No Abstract] [Full Text] [Related]
18. Ensuring access to essential medicines: some economic considerations.
Maskus KE
Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
[No Abstract] [Full Text] [Related]
19. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
Tetteh Ek
Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
[TBL] [Abstract][Full Text] [Related]
20. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
